These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 26476204

  • 1. KIR2DS4 and Its Variant KIR1D Are Associated with Acute Graft-versus-Host Disease, Cytomegalovirus, and Overall Survival after Sibling-Related HLA-Matched Transplantation in Patients with Donors with KIR Gene Haplotype A.
    Wu X, Yao Y, Bao X, Zhou H, Tang X, Han Y, Ma X, Liu Y, Chen J, Zhou H, Jing S, Gu B, Xu Y, Sun A, He J, Wu D.
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):220-225. PubMed ID: 26476204
    [Abstract] [Full Text] [Related]

  • 2. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U, Dalva K, Gungor F, Ustun C, Beksac M.
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [Abstract] [Full Text] [Related]

  • 3. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM, Kemp TJ, Dharmani-Khan P, Lewis V, Tripathi G, Rajalingam R, Daly A, Berka N, Storek J, Masood Khan F.
    PLoS One; 2016 Jun; 11(6):e0158242. PubMed ID: 27341514
    [Abstract] [Full Text] [Related]

  • 4. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
    Zhou H, Bao X, Wu X, Tang X, Wang M, Wu D, He J.
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
    [Abstract] [Full Text] [Related]

  • 5. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA, Jafari D, Mahmoodi M, Alimoghaddam K, Ostadali M, Talebzadeh Bonakdar A, Foma AM, Yekaninejad MS, Amirzargar AA.
    Turk J Med Sci; 2018 Aug 16; 48(4):794-804. PubMed ID: 30119155
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The impact of donor full-length KIR2DS4 in the development of acute and chronic GVHD after unrelated allogeneic HSCT.
    An K, Li B, Luo C, Wang J, Luo C, Chen J.
    Pediatr Transplant; 2020 Sep 16; 24(6):e13728. PubMed ID: 32594584
    [Abstract] [Full Text] [Related]

  • 8. [The impact of KIR2DS4 gene on clinical outcomes of HLA matched unrelated allo-HSCT].
    Bao XJ, He J, Sun AN, Qiu QC, Yuan XN, Chen ZX, Zhang XG.
    Zhonghua Xue Ye Xue Za Zhi; 2010 Nov 16; 31(11):726-31. PubMed ID: 21223724
    [Abstract] [Full Text] [Related]

  • 9. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
    Mansouri M, Villard J, Ramzi M, Alavianmehr A, Farjadian S.
    Hum Immunol; 2020 Jun 16; 81(6):285-292. PubMed ID: 32199702
    [Abstract] [Full Text] [Related]

  • 10. [Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation].
    Liang ZY, Ren HY, Cen XN, Qiu ZX, Wang LH, Ou JP, Li Y, Wang MJ, Wang WS, Xu WL, Dong YJ, Yin Y, Sun YH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb 16; 21(1):155-60. PubMed ID: 23484711
    [Abstract] [Full Text] [Related]

  • 11. The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor hematopoietic stem cell transplantation for myeloid malignancies.
    Wang H, He Y, Zhai WJ, Wang M, Zhou Z, Zhao YX, Feng SZ, Han MZ.
    Swiss Med Wkly; 2013 Feb 16; 143():w13717. PubMed ID: 23299929
    [Abstract] [Full Text] [Related]

  • 12. Synergistic effect of KIR ligands missing and cytomegalovirus reactivation in improving outcomes of haematopoietic stem cell transplantation from HLA-matched sibling donor for treatment of myeloid malignancies.
    Cardozo DM, Marangon AV, da Silva RF, Aranha FJP, Visentainer JEL, Bonon SHA, Costa SCB, Miranda ECM, de Souza CA, Guimarães F.
    Hum Immunol; 2016 Oct 16; 77(10):861-868. PubMed ID: 27394130
    [Abstract] [Full Text] [Related]

  • 13. The impact of KIR2DS4 alleles and the expression of KIR in the development of acute GVHD after unrelated allogeneic hematopoietic SCT.
    Bao XJ, Hou LH, Sun AN, Qiu QC, Yuan XN, Chen MH, Chen ZX, He J.
    Bone Marrow Transplant; 2010 Sep 16; 45(9):1435-41. PubMed ID: 20062104
    [Abstract] [Full Text] [Related]

  • 14. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
    McQueen KL, Dorighi KM, Guethlein LA, Wong R, Sanjanwala B, Parham P.
    Hum Immunol; 2007 May 16; 68(5):309-23. PubMed ID: 17462498
    [Abstract] [Full Text] [Related]

  • 15. Donor Killer Immunoglobulin-Like Receptor Haplotype B/x Induces Severe Acute Graft-versus-Host Disease in the Presence of Human Leukocyte Antigen Mismatch in T Cell-Replete Hematopoietic Cell Transplantation.
    Hosokai R, Masuko M, Shibasaki Y, Saitoh A, Furukawa T, Imai C.
    Biol Blood Marrow Transplant; 2017 Apr 16; 23(4):606-611. PubMed ID: 28042021
    [Abstract] [Full Text] [Related]

  • 16. The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling.
    Elfishawi SM, Mossallam GI, El-Fattah RA, El-Haddad A, Kamel AM.
    Hum Immunol; 2017 Nov 16; 78(11-12):684-691. PubMed ID: 28993188
    [Abstract] [Full Text] [Related]

  • 17. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
    Khanuntong S, Kuptawintu P, Upaisilpsathaporn K, Poolchareon A, Bunworasate U, Hirankarn N.
    HLA; 2016 Jun 16; 87(6):422-31. PubMed ID: 27273744
    [Abstract] [Full Text] [Related]

  • 18. Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
    Kanga U, Mourya M, Seth T, George J, Sood P, Sharma R, Saxena A, Mehra NK.
    Transplant Proc; 2012 May 16; 44(4):919-21. PubMed ID: 22564585
    [Abstract] [Full Text] [Related]

  • 19. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP, DA WM, Zhao DD, Wang C, Lu XC, Kang HY, Yan P, Wang FF, Zhu HY, Li HH, Gao CJ, Yu L.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3111-4. PubMed ID: 18269867
    [Abstract] [Full Text] [Related]

  • 20. An allelic typing method for 2DS4 variant used in study of haplotypes of killer cell immunoglobulin-like receptor gene.
    Bao X, Hou L, Sun A, Chen M, Chen Z, He J.
    Int J Lab Hematol; 2010 Dec 27; 32(6 Pt 2):625-32. PubMed ID: 20456519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.